Circulating tumor cells as a biomarker of response to treatment in patient derived xenograft mouse models of pancreatic adenocarcinoma

被引：2
|
作者：
Torphy, Robert J. [1 ]
Tignanelli, Christopher J. [1 ]
Moffitt, Richard A. [1 ]
Soper, Steven A. [1 ]
Yeh, Jen Jen [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2013年 / 217卷 / 03期
关键词：
D O I：
10.1016/j.jamcollsurg.2013.07.054
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：S30 / S30
页数：1
相关论文
共 50 条
  • [41] Prognostic Value of Circulating Tumor Cells in Patients With Pancreatic Adenocarcinoma
    Cauley, C. E.
    Pittman, M.
    Zhou, J.
    Valsangkar, N.
    Liss, A.
    Fernandez-del Castillo, C.
    Warshaw, A. L.
    Lillemoe, K. D.
    Thayer, S. P.
    PANCREAS, 2013, 42 (08) : 1342 - 1342
  • [42] Circulating tumor DNA as a biomarker for treatment response in an advanced Merkel cell carcinoma patient
    Yeakel, J.
    Hook, N.
    Yamamoto, M.
    Kannan, A.
    Sanzaro, E.
    Aleshin, A.
    Harris, J.
    Gao, L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S77 - S77
  • [43] Circulating tumor cell clusters and circulating tumor cell-derived explant models as a tool for treatment response
    Prasanna, Biderahalli Kruthika
    Balakrishnan, Ajay
    Kumar, Prashant
    BIOTECHNIQUES, 2020, 69 (01) : 5 - 6
  • [44] Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment
    Kuracha, Murali R.
    Thomas, Peter
    Loggie, Brian W.
    Govindarajan, Venkatesh
    CANCER MEDICINE, 2016, 5 (04): : 711 - 719
  • [45] Live circulating tumor cells as a predictive biomarker of response to neoadjuvant chemoradiotherapy for resectable pancreatic cancer
    Tanemura, Masahiro
    Furukawa, Kenta
    Wakasugi, Masaki
    Kishi, Kentaro
    Urata, Yasuo
    Taniyama, Kiyomi
    Akamatsu, Hiroki
    CANCER RESEARCH, 2016, 76
  • [46] Application of circulating tumor cells and circulating cell-free DNA to assess the pharmacodynamic response to chemotherapy in xenograft models
    Bao, Haifeng
    Burke, Patricia
    Zhong, Haihong
    Chen, Xiaoru
    Chen, Tracy
    Czapiga, Meggan
    Dacosta, Karma
    Jallal, Bahija
    Chang, Yong
    Coats, Steven
    Richman, Laura
    LaVallee, Theresa
    CANCER RESEARCH, 2010, 70
  • [47] Application of Drug Testing Platforms in Circulating Tumor Cells and Validation of a Patient-Derived Xenograft Mouse Model in Patient with Primary Intracranial Ependymomas with Extraneural Metastases
    Liang, Muh-Lii
    Yeh, Ting-Chi
    Huang, Man-Hsu
    Wu, Pao-Shu
    Wu, Shih-Pei
    Huang, Chun-Chao
    Yen, Tsung-Yu
    Ting, Wei-Hsin
    Hou, Jen-Yin
    Huang, Jia-Yun
    Ding, Yi-Huei
    Zheng, Jia-Huei
    Liu, Hsi-Che
    Ho, Che-Sheng
    Chen, Shiu-Jau
    Hsieh, Tsung-Han
    DIAGNOSTICS, 2023, 13 (07)
  • [48] Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal Adenocarcinoma
    Tanaka, Ryota
    Kageyama, Ken
    Kimura, Kenjiro
    Eguchi, Shinpei
    Tauchi, Jun
    Shinkawa, Hiroji
    Ohira, Go
    Yamazoe, Sadaaki
    Yamamoto, Akira
    Tanaka, Shogo
    Amano, Ryosuke
    Tanaka, Hiroaki
    Yashiro, Masakazu
    Kubo, Shoji
    Ohira, Masaichi
    ANTICANCER RESEARCH, 2020, 40 (05) : 2637 - 2644
  • [49] Application of quantitative analysis of mouse cell contamination and purification of human tumor cells in patient derived orthotopic xenograft mouse models of pediatric brain tumors
    Braun, Frank K.
    Kogiso, Mari
    Qi, Lin
    Zhang, Huiyuan
    Du, Yuchen
    Lindsay, Holly B.
    Zhao, Sibo
    Injac, Sarah G.
    Li, Xiao-Nan
    CANCER RESEARCH, 2017, 77
  • [50] COMPARISON OF PKPD MODELS FOR BIOMARKER RESPONSE AND TUMOR GROWTH INHIBITION TO AN ORALLY AVAILABLE CMET KINASE INHIBITOR IN MOUSE XENOGRAFT MODELS
    Yamazaki, Shinji
    Skaptason, Judith
    Romero, David
    Lee, Joseph
    Zou, Helen
    Christensen, James
    Koudriakova, Tatiana
    DRUG METABOLISM REVIEWS, 2007, 39 : 371 - 372
12345